Josée P A Wagenaar

Suggest Changes
Learn More
OBJECTIVE To prevent and treat experimental arthritis via nasal administration of an altered peptide ligand (APL) from the major arthritogenic epitope in adjuvant-induced arthritis (AIA) and to(More)
  • 1